Brokerages expect Surgery Partners Inc (NASDAQ:SGRY) to post $449.18 million in sales for the current fiscal quarter, according to Zacks Investment Research. Four analysts have provided estimates for Surgery Partners’ earnings, with the highest sales estimate coming in at $451.52 million and the lowest estimate coming in at $448.00 million. Surgery Partners posted sales of $444.78 million during the same quarter last year, which suggests a positive year-over-year growth rate of 1%. The company is scheduled to report its next earnings report on Thursday, August 8th.
On average, analysts expect that Surgery Partners will report full-year sales of $1.85 billion for the current year, with estimates ranging from $1.82 billion to $1.88 billion. For the next year, analysts expect that the business will report sales of $2.01 billion, with estimates ranging from $1.91 billion to $2.12 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research firms that that provide coverage for Surgery Partners.
Surgery Partners (NASDAQ:SGRY) last issued its quarterly earnings results on Wednesday, May 8th. The company reported ($0.42) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.39) by ($0.03). The firm had revenue of $416.80 million during the quarter, compared to analyst estimates of $421.41 million. Surgery Partners had a negative return on equity of 4.01% and a negative net margin of 11.59%. The business’s revenue was up 1.3% on a year-over-year basis. During the same period in the prior year, the firm earned ($0.26) earnings per share.
In other Surgery Partners news, Director Adam T. Feinstein sold 7,865 shares of the business’s stock in a transaction on Monday, May 20th. The stock was sold at an average price of $9.95, for a total transaction of $78,256.75. Following the transaction, the director now owns 8,895 shares of the company’s stock, valued at $88,505.25. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 2.30% of the company’s stock.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Principal Financial Group Inc. boosted its stake in Surgery Partners by 9.5% during the fourth quarter. Principal Financial Group Inc. now owns 19,325 shares of the company’s stock worth $189,000 after buying an additional 1,672 shares during the last quarter. BNP Paribas Arbitrage SA boosted its stake in Surgery Partners by 3.0% during the first quarter. BNP Paribas Arbitrage SA now owns 104,284 shares of the company’s stock worth $1,176,000 after buying an additional 3,068 shares during the last quarter. California Public Employees Retirement System boosted its stake in Surgery Partners by 11.3% during the fourth quarter. California Public Employees Retirement System now owns 36,917 shares of the company’s stock worth $361,000 after buying an additional 3,739 shares during the last quarter. Quantamental Technologies LLC acquired a new position in Surgery Partners during the first quarter worth $50,000. Finally, Metropolitan Life Insurance Co. NY raised its position in Surgery Partners by 351.4% in the fourth quarter. Metropolitan Life Insurance Co. NY now owns 6,766 shares of the company’s stock valued at $66,000 after purchasing an additional 5,267 shares during the period. 96.75% of the stock is currently owned by institutional investors.
Shares of NASDAQ:SGRY traded down $0.16 during trading on Tuesday, reaching $7.90. The stock had a trading volume of 259,128 shares, compared to its average volume of 359,082. The company has a current ratio of 1.49, a quick ratio of 1.37 and a debt-to-equity ratio of 2.20. The stock has a fifty day moving average of $8.81. The company has a market cap of $390.48 million, a PE ratio of -3.22 and a beta of 2.28. Surgery Partners has a 1-year low of $7.64 and a 1-year high of $18.70.
About Surgery Partners
Surgery Partners, Inc, through its subsidiaries, owns and operates a network of surgical facilities and related services in the United States. The company operates through three segments: Surgical Facility Services, Ancillary Services, and Optical Services. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management.
See Also: Cost of Goods Sold (COGS)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Surgery Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners and related companies with MarketBeat.com's FREE daily email newsletter.